These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37060264)

  • 21. What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida?
    Dorey L; Hobson S; Lees P
    J Vet Pharmacol Ther; 2017 Oct; 40(5):517-529. PubMed ID: 28101885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic and pharmacodynamic characterization of ceftiofur crystalline-free acid following subcutaneous administration in domestic goats.
    Waraich GS; Sidhu PK; Daundkar PS; Kaur G; Sharma SK
    J Vet Pharmacol Ther; 2017 Oct; 40(5):429-438. PubMed ID: 27943295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens.
    Dorey L; Lees P
    BMC Vet Res; 2017 Jun; 13(1):192. PubMed ID: 28645327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of standardised versus non-standardised methods for testing the in vitro potency of oxytetracycline against Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Illambas J; Pelligand L; Toutain PL
    Vet J; 2016 Dec; 218():60-64. PubMed ID: 27938710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Potter T; Pelligand L; Toutain PL
    J Vet Pharmacol Ther; 2018 Feb; 41(1):28-38. PubMed ID: 28736817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model.
    Qu Y; Qiu Z; Cao C; Lu Y; Sun M; Liang C; Zeng Z
    BMC Vet Res; 2015 Dec; 11():294. PubMed ID: 26631082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Pelligand L; Cheng Z; Lees P
    J Vet Pharmacol Ther; 2017 Oct; 40(5):505-516. PubMed ID: 28090673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ceftaroline versus isolates from animal bite wounds: comparative in vitro activities against 243 isolates, including 156 Pasteurella species isolates.
    Goldstein EJ; Citron DM; Merriam CV; Tyrrell KL
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6319-23. PubMed ID: 23027193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic-pharmacodynamic integration and modelling of florfenicol in calves.
    Sidhu P; Rassouli A; Illambas J; Potter T; Pelligand L; Rycroft A; Lees P
    J Vet Pharmacol Ther; 2014 Jun; 37(3):231-42. PubMed ID: 24341543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida.
    Potter T; Illambas J; Pelligand L; Rycroft A; Lees P
    Vet J; 2013 Jan; 195(1):53-8. PubMed ID: 23084327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bactericidal properties of pradofloxacin against veterinary pathogens.
    Silley P; Stephan B; Greife HA; Pridmore A
    Vet Microbiol; 2012 May; 157(1-2):106-11. PubMed ID: 22209121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial activity of cathelicidins BMAP28, SMAP28, SMAP29, and PMAP23 against Pasteurella multocida is more broad-spectrum than host species specific.
    Brogden KA; Nordholm G; Ackermann M
    Vet Microbiol; 2007 Jan; 119(1):76-81. PubMed ID: 16997510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative quantification of the in vitro activity of veterinary fluoroquinolones.
    Grobbel M; Lübke-Becker A; Wieler LH; Froyman R; Friederichs S; Filios S
    Vet Microbiol; 2007 Sep; 124(1-2):73-81. PubMed ID: 17498893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial activity of combined aditoprim and sulfamethoxazole against Escherichia coli from swine and a dose regimen based on pharmacokinetic-pharmacodynamic modeling.
    Wang F; Luo W; Pan Y; Qu W; Xie S; Huang L; Wang Y
    J Vet Pharmacol Ther; 2022 Jan; 45(1):133-145. PubMed ID: 34435681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic-pharmacodynamic relationship of marbofloxacin for Escherichia coli and Pasturella multocida following repeated intramuscular administration in goats.
    Bhardwaj P; Sidhu PK; Saini SPS; M B D; Rampal S
    J Vet Pharmacol Ther; 2019 Jul; 42(4):430-439. PubMed ID: 31102281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates.
    Spreng M; Deleforge J; Thomas V; Boisramé B; Drugeon H
    J Vet Pharmacol Ther; 1995 Aug; 18(4):284-9. PubMed ID: 8583541
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Kong Y; Li C; Li G; Yang T; Draz MS; Xie X; Zhang J; Ruan Z
    Microbiol Spectr; 2022 Jun; 10(3):e0009922. PubMed ID: 35532225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic-pharmacodynamic integration of marbofloxacin after single and repeated intravenous administration in goats.
    Bhardwaj P; Sidhu PK; Lonare MK; Kaur R; Dumka VK; Rampal S
    Res Vet Sci; 2018 Dec; 121():111-115. PubMed ID: 30384141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survey of susceptibility to marbofloxacin in bacteria isolated from diseased pigs in Europe.
    El Garch F; Kroemer S; Galland D; Morrissey I; Woehrle F
    Vet Rec; 2017 Jun; 180(24):591. PubMed ID: 28348142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative pharmacokinetics of danofloxacin in healthy and Pasteurella multocida infected ducks.
    Xiao X; Lan W; Wang Y; Jiang L; Jiang Y; Wang Z
    J Vet Pharmacol Ther; 2018 Dec; 41(6):912-918. PubMed ID: 30182430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.